- Liquidity
- $>999T
- Volume 24h
- $0
- FDV
- $>999T
- Supply
- 1.00B
About Genome Sequencing
As genome sequencing costs have fallen, the number of sequenced genomes has soared. Graph is from 2019, but progress has continued. https://www.forbes.com/sites/kenberman/2019/02/21/genome-sequencing-stocks-on-the-rise/
Safety
No flags- OwnerNone
- UpgradeableNo
- Can mintNo
- Can pause or blacklistNo
- Sellers, 24h0
Read from the contract and recent trades: a heuristic, not an audit.
Pairs 1
| Watch# | Pair | Price |
|---|---|---|
| $>999T– |